Trial Profile
A Study to Evaluate the Natalizumab Transfer in Breast Milk and Serum Of Newborn Babies in Women With Relapsing Remitting Multiple Sclerosis (RRMS) Who Continued Natalizumab Treatment During Pregnancy and Lactation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2016
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- 26 Feb 2016 New trial record